RAICHUR,India,March 12,2025--Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED),a leading API and formulation manufacturer,announces that the Subject Expert Committee (SEC) of CDSCO has approved
BEIJING,March 8,2025-- A news report fromchinadaily.com.cn： The intensified multilateral and bilateral exchanges between China and other countries and regions have led to an increase in foreign-relat
OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the FDA Regulatory approval for interchangeability was supported by positive phase III data demonstrating compar
BEIJING,March 10,2025-- A news report fromchinadaily.com.cn： In 2024,China expanded its high-level opening-up and achieved fruitful results.
Join Our Event at the Pullman Jakarta Central Park on 23 March 2025 HONG KONG,March 10,2025-- Choosing the right university is a pivotal decision for many students,given the numerous options and the c
CHINO HILLS,Calif.,March 10,2025-- This March,RITFIT has launched a series of events under the theme "Empowering Women: Health and Strength in the Home Gym," in alignment with this year\'s I
